{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:27:08Z","timestamp":1778048828717,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN2020"],"award-info":[{"award-number":["PRIN2020"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2020833Y75"],"award-info":[{"award-number":["2020833Y75"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","award":["RFO 2023-24"],"award-info":[{"award-number":["RFO 2023-24"]}],"id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117965","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:34:36Z","timestamp":1752582876000},"page":"117965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting \u03b14\u03b21 integrin: from cyclic to linear ligands, effects of chemical modifications"],"prefix":"10.1016","volume":"297","author":[{"given":"Valentina","family":"Giraldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Maurizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Magnone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bedini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0363-0633","authenticated-orcid":false,"given":"Monica","family":"Baiula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8038-3926","authenticated-orcid":false,"given":"Daria","family":"Giacomini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117965_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117965_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","article-title":"The integrins","volume":"8","author":"Takada","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2025.117965_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117965_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.25.022106.141618","article-title":"Structural basis of integrin regulation and signaling","volume":"25","author":"Luo","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/boc.201700060","article-title":"Integrin diversity brings specificity in mechanotransduction","volume":"110","author":"Seetharaman","year":"2018","journal-title":"Biol. Cell"},{"key":"10.1016\/j.ejmech.2025.117965_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1083\/jcb.201609037","article-title":"Integrin-mediated mechanotransduction","volume":"215","author":"Sun","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117965_bib7","doi-asserted-by":"crossref","first-page":"E3872","DOI":"10.1073\/pnas.1605074113","article-title":"Relating conformation to function in integrin \u03b15\u03b21","volume":"113","author":"Su","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117965_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/acsnano.3c06253","article-title":"Force-regulated spontaneous conformational changes of integrins \u03b15\u03b21 and \u03b1V\u03b23","volume":"18","author":"Yunfeng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2025.117965_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10237-023-01805-3","article-title":"A molecular arm: the molecular bending\u2013unbending mechanism of integrin","volume":"23","author":"Li","year":"2024","journal-title":"Biomech. Model. Mechanobiol."},{"key":"10.1016\/j.ejmech.2025.117965_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00441-009-0834-6","article-title":"Integrins","volume":"339","author":"Barczyk","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejmech.2025.117965_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004994","article-title":"Integrin structure, activation, and interactions","volume":"3","author":"Campbell","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejmech.2025.117965_bib12","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.3390\/ijms24076170","article-title":"The interplay between integrins and immune cells as a regulator in cancer immunology","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117965_bib13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/cells13030212","article-title":"Integrins in health and disease, suitable targets for treatment?","volume":"13","author":"Klaus","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117965_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.117965_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.immunol.021908.132554","article-title":"The ins and outs of leukocyte integrin signaling","volume":"27","author":"Abram","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib16","first-page":"1841","article-title":"LFA-1 and Mac-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ","volume":"49","author":"Sumagin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0227-1","article-title":"LFA-1 (CD11a\/CD18) and Mac-1 (CD11b\/CD18) distinctly regulate neutrophil extravasation through hotspots I and II","volume":"51","author":"Hyun","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117965_bib18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3390\/biom13060892","article-title":"Targeting neutrophil \u03b22-integrins: a review of relevant resources, tools, and methods","volume":"13","author":"Conley","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.117965_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1344761","article-title":"SKAP2 acts downstream of CD11b\/CD18 and regulates neutrophil effector function","volume":"15","author":"Bouti","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1189\/jlb.0804460","article-title":"Targeting leukocyte integrins in human diseases","volume":"77","author":"Yonekawa","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejmech.2025.117965_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2014.11.008","article-title":"Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease","volume":"147","author":"Mitroulis","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117965_bib22","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3389\/fimmu.2017.01866","article-title":"\u03b22 Integrins as regulators of dendritic cell, monocyte, and macrophage function","volume":"8","author":"Schittenhelm","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cei\/uxad093","article-title":"Targeting T-cell integrins in autoimmune and inflammatory diseases","volume":"215","author":"Kelly","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/biom15020233","article-title":"Integrins in cardiovascular health and disease: molecular mechanisms and therapeutic opportunities","volume":"15","author":"\u0141awkowska","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.117965_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-023-01338-3","article-title":"Integrin \u03b2-1 in disorders and cancers: molecular mechanisms and therapeutic targets","volume":"22","author":"Su","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2025.117965_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11307-021-01666-1","article-title":"PET imaging of VLA-4 in a new BRAFV600E mouse model of melanoma","volume":"24","author":"Bellavia","year":"2022","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.ejmech.2025.117965_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154152","article-title":"LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade","volume":"132","author":"Hickman","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117965_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fchem.2019.00489","article-title":"Novel ligands targeting \u03b14\u03b21 integrin: therapeutic applications and perspectives","volume":"7","author":"Baiula","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3390\/biomedicines12020316","article-title":"Conjecturing about small-molecule agonists and antagonists of \u03b14\u03b21 integrin: from mechanistic insight to potential therapeutic applications","volume":"12","author":"He","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.117965_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/ijms19020449","article-title":"Beyond the matrix: the many non-ECM ligands for integrins","volume":"19","author":"LaFoya","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117965_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2006.07.016","article-title":"Activation of leukocyte beta2 integrins by conversion from bent to extended conformations","volume":"25","author":"Nishida","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2025.117965_bib32","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1021\/acs.jmedchem.9b01869","article-title":"Insights into protein-ligand interactions in integrin complexes: advances in structure determinations","volume":"63","author":"Zheng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib33","doi-asserted-by":"crossref","first-page":"21785","DOI":"10.1074\/jbc.R000003200","article-title":"Ligand binding to integrins","volume":"275","author":"Plow","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib34","doi-asserted-by":"crossref","first-page":"21341","DOI":"10.1074\/jbc.272.34.21341","article-title":"An RGD to LDV motif conversion within the disintegrin kistrin generates an integrin antagonist that retains potency but exhibits altered receptor specificity. Evidence for a functional equivalence of acidic integrin-binding motifs","volume":"272","author":"Tselepis","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib35","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.4049\/jimmunol.157.6.2488","article-title":"Mucosal addressing cell adhesion molecule-1: a structural and functional analysis demarcates the integrin binding motif","volume":"157","author":"Viney","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103250","article-title":"Novel inhibitors of leukocyte transendothelial migration","volume":"92","author":"Getter","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib37","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/1521-3773(20020816)41:16<3007::AID-ANIE3007>3.0.CO;2-3","article-title":"Combinatorial and rational strategies to develop nonpeptidic alpha4beta7-integrin antagonists from cyclic peptides","volume":"41","author":"Gottschling","year":"2002","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2025.117965_bib38","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1021\/jm049657b","article-title":"Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazole-2-one derivatives","volume":"47","author":"Wu","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib39","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd3266","article-title":"Integrins as therapeutic targets: lessons and opportunities","volume":"9","author":"Cox","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117965_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrd.2015.10","article-title":"Integrin-based therapeutics: biological basis, clinical use and new drugs","volume":"15","author":"Ley","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117965_bib41","first-page":"648","article-title":"AJM300 (carotegrast methyl), an oral antagonist of \u03b14-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study, Lancet Gastroenterol","volume":"7","author":"Matsuoka","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117965_bib42","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1021\/acs.jmedchem.6b00576","article-title":"New \u03b2-lactam derivatives modulate cell adhesion and signaling mediated by RGD-binding and leukocyte integrins","volume":"59","author":"Baiula","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib43","doi-asserted-by":"crossref","first-page":"10156","DOI":"10.1021\/acs.jmedchem.9b01000","article-title":"Could dissecting the molecular framework of \u03b2-lactam integrin ligands enhance selectivity?","volume":"62","author":"Martelli","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau9240","article-title":"Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies","volume":"11","author":"Panni","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117965_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ccell.2023.04.018","article-title":"Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.117965_bib46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/acs.biomac.9b01550","article-title":"Combining biologically active \u03b2-lactams integrin agonists with poly(l-lactic acid) nanofibers: enhancement of human mesenchymal stem cell adhesion","volume":"21","author":"Martelli","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2025.117965_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111580","article-title":"Strontium substituted hydroxyapatite with \u03b2-lactam integrin agonists to enhance mesenchymal cells adhesion and to promote bone regeneration","volume":"200","author":"Cirillo","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejmech.2025.117965_bib48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/acsabm.2c00890","article-title":"Poly(l-lactic acid) scaffold releasing an \u03b14\u03b21 integrin agonist promotes nonfibrotic skin wound healing in diabetic mice","volume":"16","author":"Baldassarro","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ejmech.2025.117965_bib49","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1021\/acs.jmedchem.2c02098","article-title":"Design and pharmacological characterization of \u03b14\u03b21 integrin cyclopeptide agonists: computational investigation of ligand determinants for agonism versus antagonism","volume":"66","author":"Anselmi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib50","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib51","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B610213C","article-title":"Fluorine in medicinal chemistry","volume":"37","author":"Purser","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2025.117965_bib52","doi-asserted-by":"crossref","first-page":"20337","DOI":"10.1074\/jbc.M000568200","article-title":"Molecular basis of ligand recognition by integrin alpha5beta1. II. Specificity of Arg-Gly-Asp binding is determined by Trp157 of the alpha subunit","volume":"275","author":"Humphries","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib53","doi-asserted-by":"crossref","first-page":"17863","DOI":"10.1073\/pnas.1420645111","article-title":"Metal ion and ligand binding of integrin \u03b15\u03b21","volume":"111","author":"Xia","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2025.117965_bib54","doi-asserted-by":"crossref","first-page":"ar56","DOI":"10.1091\/mbc.E21-11-0536","article-title":"Regulation of integrin \u03b15\u03b21 conformational states and intrinsic affinities by metal ions and the ADMIDAS","volume":"33","author":"Anderson","year":"2022","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2025.117965_bib55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.15252\/embj.201695803","article-title":"Conformational equilibria and intrinsic affinities define integrin activation","volume":"36","author":"Li","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.117965_bib56","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.cell.2022.08.008","article-title":"A general chemical principle for creating closure-stabilizing integrin inhibitors","volume":"185","author":"Lin","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117965_bib57","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1177\/0271678X19880161","article-title":"Integrin \u03b15\u03b21 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke","volume":"40","author":"Edwards","year":"2020","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejmech.2025.117965_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662164","article-title":"The promiscuous profile of complement receptor 3 in ligand binding, immune modulation, and pathophysiology","volume":"12","author":"Lamers","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib59","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.str.2024.04.013","article-title":"\u03b1MI-domain of integrin Mac-1 binds the cytokine pleiotrophin using multiple mechanisms","volume":"32","author":"Nguyen","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2025.117965_bib60","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/bi5013782","article-title":"Ligand recognition specificity of leukocyte integrin \u03b1M\u03b22 (Mac-1, CD11b\/CD18) and its functional consequences","volume":"54","author":"Podolnikova","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117965_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001811","article-title":"Small molecule-mediated activation of the integrin CD11b\/CD18 reduces inflammatory disease","volume":"4","author":"Maiguel","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2025.117965_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103551","article-title":"AlphaFold, allosteric, and orthosteric drug discovery: ways forward","volume":"28","author":"Nussinov","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117965_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003005","article-title":"GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors","volume":"9","author":"DeNardo","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejmech.2025.117965_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.619925","article-title":"\u03b22 Integrin signaling cascade in neutrophils: more than a single function","volume":"11","author":"Bouti","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117965_bib65","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fonc.2020.00748","article-title":"Positive allosteric modulation of CD11b as a novel therapeutic strategy against lung cancer","volume":"10","author":"Geraghty","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.117965_bib66","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/biom14081003","article-title":"Development of VLA4 and CXCR4 antagonists for the mobilization of hematopoietic stem and progenitor cells","volume":"14","author":"Ruminski","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.117965_bib67","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3390\/biomedicines12020316","article-title":"Conjecturing about small-molecule agonists and antagonists of \u03b14\u03b21 integrin: from mechanistic insight to potential therapeutic applications","volume":"12","author":"He","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.117965_bib68","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1073\/pnas.1918721117","article-title":"Activation by substoichiometric inhibition","volume":"117","author":"Merdanovic","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117965_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108193","article-title":"Importance of integrin transmembrane helical interactions for antagonistic versus agonistic ligand behavior: consequences for medical applications","volume":"156","author":"Reuning","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib70","doi-asserted-by":"crossref","first-page":"37904","DOI":"10.1074\/jbc.M606888200","article-title":"A small molecule agonist of an integrin, \u03b1L\u03b22","volume":"281","author":"Yang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117965_bib71","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1074\/jbc.M115.705624","article-title":"\u03b2-Subunit binding is sufficient for ligands to open the integrin \u03b1IIb\u03b23 headpiece","volume":"291","author":"Lin","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib72","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41580-022-00531-5","article-title":"Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions","volume":"24","author":"Kanchanawong","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117965_bib73","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/CIRCRESAHA.111.257980","article-title":"Opening the field of integrin biology to \"biased agonism\"","volume":"109","author":"Simon","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.117965_bib74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/cancers9070078","article-title":"Can integrin agonists have cards to play against cancer? A literature survey of small molecules integrin activators","volume":"9","author":"Tolomelli","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.117965_bib75","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/cells12151977","article-title":"CD40L activates platelet integrin \u03b1IIb\u03b23 by binding to the allosteric site (site 2) in a KGD-independent manner and HIGM1 mutations are clustered in the integrin-binding sites of CD40L","volume":"12","author":"Takada","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117965_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115504","article-title":"Allosteric targeting resolves limitations of earlier LFA-1 directed modalities","volume":"211","author":"Mancuso","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117965_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100399","article-title":"Soluble CD40L activates soluble and cell-surface integrin \u03b1v\u03b23, \u03b15\u03b21, and \u03b14\u03b21 by binding to the allosteric ligand-binding site (site 2)","volume":"296","author":"Takada","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib78","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/jm980032l","article-title":"Synthesis and quantitative structure\u2212activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective \u03c31 receptor ligands","volume":"41","author":"Huang","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127676","article-title":"Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists","volume":"34","author":"Bae","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117965_bib80","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1002\/anie.201602382","article-title":"Iminium catalysis inside a self-assembled supramolecular capsule: modulation of enantiomeric excess","volume":"55","author":"Br\u00e4uer","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117965_bib81","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2014.06.041","article-title":"Targeting integrins \u03b1v\u03b23 and \u03b15\u03b21 with new \u03b2-lactam derivatives","volume":"83","author":"Galletti","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib82","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/j.bmcl.2005.06.006","article-title":"Analysis of structure\u2013activity relationships for the \u2018B-region\u2019 of N-(4-t-butylbenzyl)-N\u2032-[4-(methyl sulfonylamino) benzyl]-thiourea analogues as TRPV1 antagonists","volume":"15","author":"Lee","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117965_bib83","first-page":"283","article-title":"A Method for the selective protection of aromatic amines in the presence of aliphatic amines","volume":"2","author":"Perron","year":"2009","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2025.117965_bib84","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1021\/acs.oprd.5b00134","article-title":"Enantiomerically pure dibenzyl esters of l-Aspartic and l-Glutamic acid","volume":"19","author":"Bolchi","year":"2015","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2025.117965_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115342","article-title":"Bifunctional degraders of cyclin dependent kinase 9 (CDK9): probing the relationship between linker length, properties, and selective protein degradation","volume":"254","author":"Tokarski","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117965_bib86","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1111\/bph.14458","article-title":"DS-70, a novel and potent \u03b14 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in Guinea pigs","volume":"175","author":"Dattoli","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117965_bib87","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.3390\/ijms24119588","article-title":"Design, pharmacological characterization, and molecular docking of minimalist peptidomimetic antagonists of \u03b14\u03b21 integrin","volume":"24","author":"Baiula","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117965_bib88","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/acsptsci.1c00094","article-title":"Selective integrin ligands promote cell internalization of the antineoplastic agent fluorouracil","volume":"4","author":"Baiula","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:45Z","timestamp":1777529325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425007305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":88,"alternative-id":["S0223523425007305"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117965","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting \u03b14\u03b21 integrin: from cyclic to linear ligands, effects of chemical modifications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117965"}}